A 45-year-old womanwas admitted because of hypertension and hypokalemia. Primary amenorrhea from birth was noted. Plasma renin activity (PRA), 17a-hydroxyprogesterone and androgen levels were low, but progesterone, 1 1 -deoxycorticosterone, corticosterone and adrenocorticotropic hormone (ACTH)were elevated, resulting in a diagnosis of 17oc-hydroxylase deficiency. Abdominal magnetic resonance imaging revealed a round mass in the left adrenal region, the specimen of which was diagnosed as myelolipoma. After removal of the tumor, the blood pressure, serum potassium and hormonelevels were unchanged, indicating an adrenal non-functioning tumor. Excessive ACTH secretion over a long period maystimulate the development of adrenal myelolipoma. (Internal Medicine 40: 920-923, 2001) 
Introduction 17oc-Hydroxylasedeficiency is a rare cause of congenital adrenal hyperplasia leading to hypertension and hypokalemia due to excessive production of mineralocorticoid hormone ( 1) . In addition, impaired production of sex hormones causes sexual development abnormalities (1, 2) . The disease is caused by a defect in cytochrome P450c17, the single enzyme that has 17a-hydroxylase and 17, 20-lyase activities (3, 4) . In spite of increased levels of 1 1 -deoxycorticosterone (DOC)and corticosterone which give rise to hypertension and hypokalemia (1) , low aldosterone levels with suppressed plasma renin activity (PRA) have also been described in 1 7oc-hydroxylase deficiency (5, 6) . Adrenal myelolipomas are also rare, hormonally inactive, benign neoplasmas composedof mature adipose and hematopoietic tissues (7, 8) .
Here, we report here on a case of 17a-hydroxylase deficiency with normal aldosterone levels accompanied with adrenal myelolipoma.
Case Report
A 45-year-old womancame to our hospital because of hypertension and hypokalemia. Hypertension was indicated at age 40. She had been given 2.5-5 mg of amlodipine besilate from age 44 by a practitioner. However, blood pressure levels had been high (150-170/90-100 mmHg) and plasma potassium levels had been low (2.3-2.6 mEq/Z). Primary amenorrhea from birth was noted. She did not smoke or drink alcohol. There was no consanguinity. Her mother also had hypertension. Her physical examination showed the following findings: height 174 cm, weight 69 kg (body mass index: 22.8 kg/m2), blood pressure 160/100 mmHg,pulse rate 76/min. Funduscopic examination did not show hypertensive retinopathy (Scheie H^). The breasts were hypoplastic. A grade 1 systolic ejection murmur was heard at the apex. The vagina was atrophic. There was no pubic or axillary hair. Laboratory data were as follows: electrocardiogram showed U waves in all leads. The serum sodium level was 148 mEq//; potassium, 2.5 mEq// and chloride, 106 mEq//. The urine potassium level was 65 mEq//. The arterial blood pH showed slight alkalosis (pH 7.457) and base excess, +7.5 mEq//. All other chemical analyses were normal. Results of hormonal studies are summarized in Tables 1 and 2 . Basal PRA, 17a-hydroxyprogesterone, dehydroepiandrosterone sulfate (DHEA-S), testosterone, estradiol and urinary excretion of 17KSwere low, but blood levels of adrenocorticotropic hormone (ACTH) progesterone, DOCand corticosterone were elevated. Cortisol, aldosterone and urinary excretion of 17-OHCSand catecholamine (such as urinary metanephrine) levels were within the normal range (Table 1A) . PRAfailed to respond to 2-hour upright posture after an intravenous administration of 40 mg furosemide. Plasma levels of aldosterone were nearly unchanged (Table IB) . Plasma ACTH, cortisol and aldosterone levels showed diurnal rhythm. Administration of 1 mg dexam- ethasone at 2300 h decreased plasma levels ofACTH, cortisol and aldosterone at 0600 h on the next day (Table 1C) . Corticotrophin-releasing hormone (CRH) ( 100 (ig), -growth hormone-releasing hormone (GRH) ( 1 00 |xg), -thyrotropin-releasing hormone (TRH) (500 | Lig), -luteinizing hormone-releasing hormone (LHRH) (100 |ig) loading test showed a normal response of GH, thyroid stimulating hormone (TSH), prolactin or LH. Basal ACTHlevels were high and hyperresponsive, while cortisol wasalmost unchanged. Basal follicle stimulating hormone (FSH) levels were also high and had a low response (Table 2) . Although adrenal scintiscanning using 1 31I adosterol showed a normal uptake on both sides, an abdominal echogram and magnetic resonance imaging (TW2) revealed a heterogeneous high intensive round mass (10x6 cm) in the left adrenal region without bilateral adrenal swelling (Fig. 1A) . Although a high ratio of aldosterone to PRAindicated primary aldosteronism, plasma levels of cortisol and aldosterone were nearly unchanged in bilateral adrenal vein samples (data not shown). The left adrenal tumor was subsequently removed. Histologieally, the tumor consisted mainly of fat cells with erythroblasts and megakaryocytes surrounding a thin normal adrenal cortex, which was a finding compatible to adrenal myelolipoma (Fig. IB) .
Her blood pressure, serum potassium, basal PRAand plasma aldosterone levels were unchanged after the operation. 17a-Hydroxyprogesterone, DHEA-S,testosterone and estradiol were still low, and progesterone, DOCand corticosterpne were still high. Aldosterone and cortisol levels remained within the normal range (Fig. 2) . These data resulted in a diagnosis of 1 7a-hydroxylase deficiency with adrenal non-functipning tumor. Subsequent chromosome (by FISH method) analysis showed 46, XY(genetic male). Before the operation, her blood pressure had ranged within 150-160/80-90 mmHgwith 5 mg amlodipine besilate and 2 mgdoxazosin mesilate a day. In the nine weeks following the operation, her blood pressure and serum potassium levels were unchanged. After giving her 1 mgof dexamethasone daily, the serum potassium levels were within 4.5 to 4.8 mEq// and the blood pressure fell. But the ACTHand aldosterone levels were still suppressed. Her blood pressure ranged from 130-140/70-80 mmHgeven when amlodipine besilate was decreased to 2.5 mg a day (Fig. 3) . The method was as follows: ACTH,GH, TSH, prolactin, LHor FSH was measured by the immunoradiometric assay method, cortisol by fluorescence polarization immunoassay, PRA, 1 7 oc-hydroxyprogesterone, progesterone, corticosterone, DOC,aldosterone or testosterone by the radioimmunoassay method and urinary catecholamine by the high-performance liquid chromatography method.
Discussion
The patient had clinical manifestations featuring by hyper- Suppression of the PRAsystem is a characteristic of mineralocorticoid excess (1) . Although the high ratio of aldosterone to PRAindicated primary aldosteronism, her blood pressure, serum potassium and PRAlevels were unchanged after the removal of the left adrenal tumor. Moreover, progesterone, DOC and corticosterone were high and 1 7oc-hydroxyprogesterone, DHEA-S, testosterone and estradiol were low, resulting in a diagnosis of 17cc-hydroxylase deficiency with adrenal nonfunctioning tumor. Seventeen oc-hydroxylase deficiency is characterized by impaired production of cortisol and compensatory ACTHhypersecretion, which stimulates large amounts of DOCand corticosterone synthesis by zona fasciculata ( 1). The increment of DOCand corticosterone mayproduce a pathological state of mineralocorticoid excess, with hypertension, hypokalemia and suppression of PRA. The zona glomerulosa is primarily controlled by angiotensin II to secrete aldosterone, while the zona fasciculata are controlled by ACTHto secrete cortisol, DOCand corticosterone (1 , 9) . The mammalian adrenal zona glomerulosa does not express 17oc-hydroxylase cytochrome P450c17, but its expression is high in the zona fasciculata ( 10) . Therefore the zona fasciculata may produce more DOCand corticosterone than aldosterone, which is produced in zona glomerulosa in the patients with 17oc-hydroxylase deficiency. However, this disorder is generally associated with a very low serum aldosterone level because the high levels of DOCand corticosterone suppress the PRAsystem (6) . In the present case, the serumaldosterone levels were normal. Several other researchers have noted similar findings. Cases with normal aldosterone levels may include mild 1 7oc-hydroxylase deficiency, which maygive rise to relatively weaksuppression of the renin-angiotensin system (1). The degree of hypertension has been variable: mild hypertension, malignant hypertension or normotensive (1 1). In hypertensive patients such as the present case, DOClevels are high basally or following corticotrophin injection, suggesting the possibility of a combined slight relative defect of 1 1-hydroxylation of DOC (ll).
Recently patients with adrenogenital syndrome such as 21-hydroxylase deficiency have shown a substantially increased incidence of adrenal incidentaloma (12, 13) . Our patient's adrenal non-functioning myelolipoma consisted of mature fat and hematopoietic elements. Most adrenal myelolipomasare asymptomatic with rare acute retroperitoneal hemorrhage. This type of tumor does not usually cause endocrine disorders (7, 8) such as the present case. Adrenal myelolipomas have been
shown to be associated with 21-hydroxylase deficiency or 17-hydroxylase deficiency ( 14 excessive ACTHsecretion, which over a long period may stimulate the development of adrenal myelolipoma. Therefore, early diagnosis and ACTHsuppression in cases of adrenogenital syndrome may help prevent adrenal myelolipoma.
